Wed, March 13, 2024
Tue, March 12, 2024
Mon, March 11, 2024
Fri, March 8, 2024

Chris Shibutani Downgraded (AMLX) to Hold and Decreased Target to $4 on, Mar 11th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -and-decreased-target-to-4-on-mar-11th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Chris Shibutani of Goldman Sachs, Downgraded "Amylyx Pharmaceuticals, Inc." (AMLX) to Hold and Decreased Target from $40 to $4 on, Mar 11th, 2024.

Chris has made no other calls on AMLX in the last 4 months.



There are 2 other peers that have a rating on AMLX. Out of the 2 peers that are also analyzing AMLX, 1 agrees with Chris's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Umer Raffat of "Evercore ISI Group" Downgraded from Buy to Hold on, Friday, March 8th, 2024


This is the rating of the analyst that currently disagrees with Chris


  • Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy with Increased Target to $32 on, Friday, March 8th, 2024

Publication Contributing Sources